Misoprostol for the Treatment of Postpartum Hemorrhage

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to test whether misoprostol is as effective as oxytocin for treating primary postpartum hemorrhage (PPH) with uterine atony as the suspected cause in two circumstances: 1) where women have received prophylactic uterotonics in the third stage of labor; and 2) where no prophylactic uterotonics have been given in the third stage of labor.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gynuity Health Projects
• Collaborator: Family Care International
• Treatments: Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• Vaginal delivery

• Postpartum hemorrhage due to suspected uterine atony

• Depending on study group: administration of prophylactic uterotonics in third stage of labor

Exclusion Criteria:

• Known allergy to misoprostol or other prostaglandin

• C-section for current delivery